Chronic endurance exercise affects paracrine action of CD31+ and CD34+ cells on endothelial tube formation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 3, 2015, Pages H407-H420

  Landers Ramos, Rian Q ^a   Sapp, Ryan M ^a   Jenkins, Nathan T ^b   Murphy, Anna E ^a   Cancre, Lucile ^a   Chin, Eva R ^a   Spangenburg, Espen E ^a   Hagberg, James M ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Angiogenesis; Circulating angiogenic cell; Exercise; Paracrine; Physical activity

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CD31 ANTIGEN; CD34 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOPROTEIN GP 91; NITRIC OXIDE; PROTEIN P47; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; PROTEIN S 100;

ADULT; ANGIOGENESIS; ARTICLE; CIRCULATING ANGIOGENIC CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDURANCE TRAINING; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; NORMAL HUMAN; OXIDATION REDUCTION STATE; PARACRINE SIGNALING; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEOMICS; ADOLESCENT; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; ENDOTHELIAL PROGENITOR CELL; EXERCISE; GENETICS; METABOLISM;

ADOLESCENT; ADULT; ANTIGENS, CD31; ANTIGENS, CD34; CASE-CONTROL STUDIES; CELLS, CULTURED; ENDOTHELIAL PROGENITOR CELLS; EXERCISE; FEMALE; HUMANS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; S100 PROTEINS;

EID: 84938629420     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00123.2015     Document Type: Article

References (63)

1. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription (8th ed.). Philadelphia: Lippincott Williams & Wilkins, 2009.
2. Arnaoutova I, George J, Kleinman HK, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12: 267-274, 2009.
3. Asahara T. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-966, 1997
4. Averill MM, Kerkhoff C, Bornfeldt KE. S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler Thromb Vasc Biol 32: 223-229, 2012.
5. 4a.Awad O. Differential healing activities of CD34+ and CD14– endothelial cell progenitors. Arterioscler Thromb Vasc Biol 26: 758-764, 2006.
6. Boizeau ML, Fons P, Cousseins L, Desjobert J, Sibrac D, Michaux C, Nestor AL, Gautret B, Neil K, Herbert C, Herault JP, Talbot H, Bono F. Automated image analysis of in vitro angiogenesis assay. J Lab Autom 18: 411-415, 2013.
7. Cotoi OS, Dunér P, Ko N, Hedblad B, Nilsson J, Björkbacka H, Schiopu A. Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals. Arterioscler Thromb Vasc Biol 34: 202-210, 2014.
8. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, Shi C, Sukhova GK, Packard RRS, Hogg N, Libby P, Simon DI. Myeloid-related protein-8/14 Is critical for the biological response to vascular injury. Circulation 120: 427-436, 2009.
9. Csiszar A, Sosnowska D, Tucsek Z, Gautam T, Toth P, Losonczy G, Colman RJ, Weindruch R, Anderson RM, Sonntag WE, Ungvari Z. Circulating factors induced by caloric restriction in the nonhuman primate macaca mulatta activate angiogenic processes in endothelial cells. J Gerontol A Biol Sci Med Sci 68: 235-249, 2013.
10. DeVan AE, Seals DR. Vascular health in the ageing athlete. Exp Physiol 97: 305-310, 2012.
11. Dimmeler S. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-397, 2001.
12. Eue I, König S, Pior J, Sorg C. S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells. Int Immunol 14: 287-297, 2002.
13. Fernandes T, Nakamuta JS, Magalhães FC, Roque FR, Lavini-Ramos C, Schettert IT, Coelho V, Krieger JE, Oliveira EM. Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. J Hypertens 30: 2133-2143, 2012.
14. Fleissner F, Thum T. Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxid Redox Signal 15: 933-948, 2011.
15. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219, 2008.
16. Groleau J, Dussault S, Haddad P, Turgeon J, Menard C, Chan JS, Rivard A. Essential role of copper-zinc superoxide dismutase for ischemia- induced neovascularization via modulation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 30: 2173- 2181, 2010.
17. Guhanarayan G, Jablonski J, Witkowski S. Circulating angiogenic cell population responses to 10 days of reduced physical activity. J Appl Physiol 117: 500-506, 2014.
18. Harraz M, Jiao C, Hanlon HD, Hartley RS, Schatteman GC. CD34- blood-derived human endothelial cell progenitors. Stem Cells 19: 304- 312, 2001.
19. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ; American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123: 933-944, 2011.
20. Hoetzer GL, Van Guilder GP, Irmiger HM, Keith RS, Stauffer BL, DeSouza CA. Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men. J Appl Physiol 102: 847-852, 2007.
21. Hur J. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293, 2003.
22. Hynes B, Kumar AHS, O’Sullivan J, Klein Buneker C, Leblond AL, Weiss S, Schmeckpeper J, Martin K, Caplice NM. Potent endothelial progenitor cell-conditioned media-related anti-apoptotic, cardiotrophic, and pro-angiogenic effects post-myocardial infarction are mediated by insulin-like growth factor-1. Eur Heart J 34: 782-789, 2011.
23. Iwakura A. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108: 3115-3121, 2003.
24. Iwakura A. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113: 1605-1614, 2006.
25. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. 1978. Br J Nutr 91: 161-168, 2004.
26. – cells. J Appl Physiol 111: 929-937, 2011.
27. Jenkins NT, Landers RQ, Thakkar SR, Fan X, Brown MD, Prior SJ, Spangenburg EE, Hagberg JM. Prior endurance exercise prevents postprandial lipaemia-induced increases in reactive oxygen species in circulating CD31+ cells. J Physiol (Lond) 589: 5539-5553, 2011.
28. Jenkins NT, Martin JS, Laughlin MH, Padilla J. Exercise-induced signals for vascular endothelial adaptations: implications for cardiovascular disease. Curr Cardiovasc Risk Rep 6: 331-346, 2012.
29. Jenkins NT, Witkowski S, Spangenburg EE, Hagberg JM. Effects of acute and chronic endurance exercise on intracellular nitric oxide in putative endothelial progenitor cells: role of NAPDH oxidase. Am J Physiol Heart Circ Physiol 2 97: H1798-H1805, 2009.
30. Jiraritthamrong C, Kheolamai P, UPratya Y, Chayosumrit M, Supokawej A, Manochantr S, Tantrawatpan C, Sritanaudomchai H, Issaragrisil S. In vitro vessel-forming capacity of endothelial progenitor cells in high glucose conditions. Ann Hematol 91: 311-320, 2011.
31. Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, Lee J, Sohn YD, Lee MY, Houge MA, Yoon YS. CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res 107: 602-614, 2010.
32. Kim SW, Kim H, Yoon YS. Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy. Regen Med 6: 335-349, 2011.
33. Kim SW, Kim H, Cho HJ, Lee JU, Levit R, Yoon Y. Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J Am Coll Cardiol 56: 593-607, 2010.
34. Kinnaird T. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685, 2004.
35. Kushner EJ, MacEneaney OJ, Morgan RG, Van Engelenburg AM, Van Guilder GP, DeSouza CA. CD31+ T cells represent a functionally distinct vascular T cell phenotype. Blood Cells Mol Dis 44: 74-78, 2010.
36. Li C, Li S, Jia C, Yang L, Song Z, Wang Y. Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis? Mediators Inflamm 2012: 1-8, 2012.
37. Linke A, Erbs S, Hambrecht R. Effects of exercise training upon endothelial function in patients with cardiovascular disease. Front Biosci 13: 424-432, 2008.
38. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA; ACT34-CMI Investigators. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 109: 428-436, 2011.
39. Luk TH, Dai YL, Siu CW, Yiu KH, Chan HT, Lee SW, Li SW, Fong B, Wong WK, Tam S, Lau CP, Tse HF. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial. Eur J Prev Cardiol 19: 830-839, 2012.
40. Lundgren DH, Hwang SI, Wu L, Han DK. Role of spectral counting in quantitative proteomics. Expert Rev Proteomics 7: 39-53, 2010.
41. MacEneaney OJ, Kushner EJ, Westby CM, Cech JN, Greiner JJ, Stauffer BL, DeSouza CA. Endothelial progenitor cell function, apopto- sis, and telomere length in overweight/obese humans. Obesity (Silver Spring) 18: 1677-1682, 2010.
42. Mackie AR, Losordo DW. CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex Heart Inst J 38: 474-485, 2011.
43. Masuda H, Kalka C, Takahashi T, Yoshida M, Wada M, Kobori M, Itoh R, Iwaguro H, Eguchi M, Iwami Y, Tanaka R, Nakagawa Y, Sugimoto A, Ninomiya S, Hayashi S, Kato S, Asahara T. Estrogenmediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 101: 598-606, 2007.
44. Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, Ito A, Liu T, Kamide C, Agrawal H, Perlman H, Qin G, Kishore R, Losordo DW. Exosomes from human CD34_ stem cells mediate their proangiogenic paracrine activity. Circ Res 109: 724-728, 2011.
45. Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol 292: H1-H18, 2007.
46. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Bloodderived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106: 571-578, 2000.
47. Schlager O, Giurgea A, Schuhfried O, Seidinger D, Hammer A, Gröger M, Fialka-Moser V, Gschwandtner M, Koppensteiner R, Steiner S. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial. Atherosclerosis 217: 240-248, 2011.
48. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond) 120: 357-375, 2011.
49. Sonnenschein K, Horvath T, Mueller M, Markowski A, Siegmund T, Jacob C, Drexler H, Landmesser U. Exercise training improves in vivo endothelial repair capacity of early endothelial progenitor cells in subjects with metabolic syndrome. Eur J Cardiovasc Prev Rehabil 18: 406-414, 2011.
50. Timmons BW. Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling. J Appl Physiol 99: 979-985, 2005.
51. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39: 733-742, 2005.
52. Van Craenenbroeck EM, Beckers PJ, Possemiers NM, Wuyts K, Frederix G, Hoymans VY, Wuyts F, Paelinck BP, Vrints CJ, Conraads VM. Exercise acutely reverses dysfunction of circulating angiogenic cells in chronic heart failure. Eur Heart J 31: 1924-1934, 2010.
53. Van Craenenbroeck EM, Conraads VM. Endothelial progenitor cells in vascular health: focus on lifestyle. Microvasc Res 79: 184-192, 2010.
54. Van Craenenbroeck EM, Hoymans VY, Beckers PJ, Possemiers NM, Wuyts K, Paelinck BP, Vrints CJ, Conraads VM. Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure. Basic Res Cardiol 105: 665-676, 2010.
55. Viemann D. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105: 2955-2962, 2005.
56. Vogl T, Gharibyan AL, Morozova-Roche LA. Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int J Mol Sci 13: 2893-2917, 2012.
57. Wang C. Mechanical, cellular, and molecular factors interact to modulate circulating endothelial cell progenitors. Am J Physiol Heart Circ Physiol 286: H1985-H1993, 2004.
58. Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG, Yeh ET. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106: 1904-1911, 2010.
59. Wang JS, Lee MY, Lien HY, Weng TP. Hypoxic exercise training improves cardiac/muscular hemodynamics and is associated with modulated circulating progenitor cells in sedentary men. Int J Cardiol 170: 315-323, 2014.
60. Witkowski S, Lockard MM, Jenkins NT, Obisesan TO, Spangenburg EE, Hagberg JM. Relationship between circulating progenitor cells, vascular function and oxidative stress with long-term training and shortterm detraining in older men. Clin Sci (Lond) 118: 303-311, 2009.
61. Yoder MC, Ingram DA. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? Biochim Biophys Acta 1796: 50-54, 2009.
62. Zhang S, Zhao L, Shen L, Xu D, Huang B, Wang Q, Lin J, Zou Y, Ge J. Comparison of various niches for endothelial progenitor cell therapy on ischemic myocardial repair: coexistence of host collateralization and Akt-mediated angiogenesis produces a superior microenvironment. Arterioscler Thromb Vasc Biol 32: 910-923, 2012.
63. Ziegelhoeffer T. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94: 230-238, 2004.